Mylan Doesn't Have to Recall Already-Shipped Generic Precedex in 'Carve-Out' Row with Hospira

A federal court has ruled that generic manufacturer Mylan does not have to recall its already-shipped versions of Hospira’s sedative Precedex, a move that reverses the court’s earlier mandate to recall all existing generic versions of the drug.
Drug Industry Daily